People | April 06, 2023
Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
Subscribe To Our Newsletter & Stay Updated
